Aimei Health Technology (NASDAQ:AFJK) Stock Crosses Above 50-Day Moving Average – Should You Sell?

Aimei Health Technology Co., Ltd. (NASDAQ:AFJK) shares crossed above its fifty day moving average during trading on Tuesday. The stock has a fifty day moving average of $12.22 and traded as high as $12.75. Aimei Health Technology shares last traded at $12.43, with a volume of 10,748 shares changing hands.

Wall Street Analysts Forecast Growth

AFJK has been the subject of several research analyst reports. Weiss Ratings lowered shares of Aimei Health Technology from a “sell (d+)” rating to a “sell (d)” rating in a research report on Friday, August 21st. Wall Street Zen raised shares of Aimei Health Technology to a “sell” rating in a research report on Saturday, September 19th. One equities research analyst has rated the stock with a Sell rating. According to MarketBeat, the company has an average rating of “Sell”.

Aimei Health Technology Stock Performance

The company has a market cap of $41.78 million, a PE ratio of 219.70 and a beta of 0.97. The stock has a 50 day moving average of $12.24 and a 200-day moving average of $26.16.

Aimei Health Technology (NASDAQ:AFJK) last issued its quarterly earnings results on Thursday, August 13th. The company reported ($0.03) EPS for the quarter.

Institutional Investors Weigh In On Aimei Health Technology

A hedge fund recently bought a new position in Aimei Health Technology stock. First Trust Capital Management L.P. bought a new stake in Aimei Health Technology Co., Ltd. (NASDAQ:AFJK) during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor bought 677,008 shares of the company’s stock, valued at approximately $8,199,000. First Trust Capital Management L.P. owned about 21.38% of Aimei Health Technology as of its most recent SEC filing. 45.58% of the stock is currently owned by institutional investors and hedge funds.

Aimei Health Technology Company Profile

Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.